A Real-World Study of Anti-SARS-CoV-2 Monoclonal Antibodies in Prophylaxis and Curative of Covid-19 (COVIMAB)

NCT05439044 · clinicaltrials.gov ↗

COMPLETED

Status

4235

Enrollment

OTHER

Sponsor class

Conditions

Immunocompromised Patients

Interventions

OTHER: Data collection

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]